State-affiliated online naloxone ordering portals across the United States differ substantially in their design, operational features, and accessibility, according to a multi-method evaluation. Among thirty-four state-affiliated portals identified across all fifty states and Washington, D.C., only 41 percent permitted orders from both individuals and organizations, while 24 percent imposed mandatory training requirements before an order could be placed.
The nationwide heuristic evaluation, conducted in July 2025, also documented notable constraints regarding product formulations and supplementary harm reduction supplies. Approximately 76 percent of the identified state portals offered exclusively intranasal naloxone, and additional supplies, such as fentanyl or xylazine testing strips, were available on only 35 percent of the platforms.
The United States continues to face an overdose crisis with nearly one million opioid-related deaths in the past two decades. While naloxone functions as an opioid antagonist that effectively reverses opioid overdoses and its distribution via state initiatives is linked to significant reductions in overdose mortality, the specific role of state-affiliated online portals had remained unexamined.
To investigate online distribution systems, the team conducted a two-part study published in the Harm Reduction Journal. The authors first evaluated state-affiliated portal features across all fifty states and Washington, D.C., coding variables including user eligibility, training mandates, order limits, naloxone formulation, and supplemental materials. They paired this nationwide analysis with a descriptive investigation of forty-eight months of administrative data, spanning January 2021 through December 2024, from Indiana’s state-affiliated naloxone portal.
Analysis of Indiana’s portal records demonstrated significant distribution volume alongside distinct ordering patterns across requestor types. Over the forty-eight-month evaluation window, the Indiana platform processed 24,553 orders and distributed more than 1,127,343 naloxone kits. Individual requesters submitted the highest proportion of total orders at 57 percent, whereas organizational distributors accounted for the largest share of physical supplies, requesting 50 percent of all kits.
The administrative data from Indiana further indicated that while portal utilization fluctuated from month to month, overall demand increased steadily from 2021 through 2024. The study’s authors concluded that substantial nationwide disparities in portal accessibility and structure demonstrate clear opportunities to broaden naloxone distribution by refining portal design and eliminating administrative hurdles.
Subject of Research: State-affiliated online naloxone portals and distribution patterns
Article Title: State naloxone portals: a national comparative content analysis and case study of Indiana
Article References: Bailey, K., Boden, M. L., Cochran, N., Aalsma, M., Reda, K., Doe-Simkins, M., & Ray, B. (2026). State naloxone portals: a national comparative content analysis and case study of Indiana. Harm Reduction Journal. https://doi.org/10.1186/s12954-026-01521-y
Image Credits: AI Generated
DOI: 10.1186/s12954-026-01521-y
Keywords: naloxone, state-affiliated portals, harm reduction, opioid overdose, overdose mortality, Indiana, heuristic evaluation, administrative data, intranasal naloxone, fentanyl testing strips, xylazine testing strips, order limits, training mandates, public health portals, naloxone distribution, overdose crisis, opioid antagonist
News Source: Glenn Wilkins. (November 10, 2026). State Naloxone Portals Differ Substantially in Design and Accessibility Nationwide. Scienmag.



